Department of Obstetrics and Gynaecology (Miss. Ghai and M Jan), Epsom & St. Helier's University Hospitals NHS Trust, Surrey, United Kingdom.
Department of Obstetrics and Gynaecology (Miss. Ghai and M Jan), Epsom & St. Helier's University Hospitals NHS Trust, Surrey, United Kingdom.
J Minim Invasive Gynecol. 2020 Jan;27(1):141-147. doi: 10.1016/j.jmig.2019.03.007. Epub 2019 Mar 15.
To examine whether existing quality of health outcome measures can be used to predict or have an association with nonresponse surgery for endometriosis.
Retrospective cohort study.
Single endometriosis referral center.
Women (n = 198) undergoing surgery for endometriosis.
Validated health questionnaires and visual analogue scales.
Patients were given validated health questionnaires, including Endometriosis Health Profile 30, Gastrointestinal Quality of Life Index, EuroQol-5, Hospital Anxiety and Depression Scale, preoperatively and at 12 months after full surgical excision of endometriosis. Visual analogue scales were also used that measured dyschezia, dysmenorrhea, dyspareunia, and chronic pelvic pain. Surgical management was dependent on severity of disease. Superficial disease was treated by laparoscopic peritoneal excision or laser ablation. Deep infiltrating disease involving the bowel was excised completely together with laparoscopic bowel surgery (shave, disc, or segmental resection) with/without concomitant total hysterectomy and bilateral salpingo-oophorectomy. Nonresponders were defined as women who failed to demonstrate an improvement in pain scores 12 months postoperatively. We examined preoperative and postoperative questionnaires, visual analogue scores, and other variables such as age at onset of symptoms, type of surgery, and the presence of postoperative complications comparing responder and nonresponder women to identify the factors associated with nonresponse. Of 102 women treated for superficial endometriosis, 25 (24.51%) were nonresponders. No factors were associated with nonresponse at 12 months. Of 96 women treated for severe endometriosis involving the bowel, 10 (10.41%) were nonresponders. Nonresponders had significantly less preoperative pain (p = .031) and feeling of control (p = .015) than responders. There was no association between nonresponders and women who underwent a hysterectomy with bilateral salpingo-oophorectomy or those with complications. Radical bowel surgery (resection) was associated with nonresponders.
Minimal preoperative factors are associated with nonresponse for women having surgery for endometriosis. The severity of pain experienced by women with endometriosis may be used to predict their response to surgery.
探讨现有的健康结局测量方法是否可用于预测或与子宫内膜异位症手术的非应答相关。
回顾性队列研究。
单一子宫内膜异位症转诊中心。
接受子宫内膜异位症手术的女性(n=198)。
验证后的健康问卷和视觉模拟量表。
患者术前和术后 12 个月接受了验证后的健康问卷,包括子宫内膜异位症健康状况 30 项问卷、胃肠道生活质量指数、EuroQol-5、医院焦虑抑郁量表。还使用了视觉模拟量表来测量排便困难、痛经、性交痛和慢性盆腔痛。手术治疗取决于疾病的严重程度。腹腔镜下切除或激光消融术治疗表浅疾病。累及肠道的深部浸润性疾病则完全切除,同时进行腹腔镜肠手术(刮除术、切割术或节段切除术),并/或同时行全子宫切除术和双侧输卵管卵巢切除术。无应答者定义为术后 12 个月疼痛评分未改善的女性。我们比较了应答者和无应答者的术前和术后问卷、视觉模拟评分以及其他变量,如症状起始年龄、手术类型和术后并发症的存在,以确定与无应答相关的因素。102 例接受表浅子宫内膜异位症治疗的女性中,25 例(24.51%)为无应答者。12 个月时无任何因素与无应答相关。96 例接受累及肠道的严重子宫内膜异位症治疗的女性中,10 例(10.41%)为无应答者。无应答者的术前疼痛(p=0.031)和控制感(p=0.015)明显低于应答者。无应答者与接受子宫切除术和双侧输卵管卵巢切除术或有并发症的女性之间无关联。根治性肠手术(切除术)与无应答者相关。
对于接受子宫内膜异位症手术的女性,仅有轻微的术前因素与手术无应答相关。子宫内膜异位症女性的疼痛严重程度可能用于预测其对手术的反应。